Medartis
| Primary URL | Location | Industry | www[.]medartis[.]com |
Country
Switzerland
|
Manufacturing
|
|---|
Profile
Medartis is a medical technology company that designs, manufactures, and distributes surgical implants and instruments primarily for trauma and extremity surgery. Its product portfolio includes locking plate systems, screws, and specialized tools intended for the treatment of fractures in the upper and lower limbs. The company serves hospitals, orthopedic surgeons, and trauma centers across multiple geographic markets. Its solutions are intended to support minimally invasive procedures and improve patient outcomes.
The source material does not disclose specific quantitative details such as employee numbers, annual revenue, or the exact size of Medartis’s global footprint. Consequently, no explicit scale or reach metrics can be stated from the provided information. However, the company’s headquarters is located in Switzerland, indicating a European base of operations. This location situates the firm within a region known for a strong medical device industry presence.
Medartis distinguishes itself through a concentrated focus on implant systems for trauma and extremity surgery, a niche within the broader orthopedic market. The firm emphasizes innovation in locking technology and anatomically contoured plates designed to enhance fixation stability. Regulatory compliance is a notable aspect, with its products typically bearing CE marking and having obtained clearances from authorities such as the U.S. Food and Drug Administration. These attributes reflect the company’s commitment to meeting stringent safety and performance standards.
Regarding the cybersecurity incident reported on May 31, 2023, Medartis successfully defended against an IT attack that caused a temporary disruption to its operations. The attack resulted in additional one‑time costs that lowered the company’s EBITDA margin by 1.7 percentage points and is estimated to have reduced first‑half revenue growth by approximately three percentage points. It also prompted a week‑long production stoppage, which incurred further manufacturing expenses. The incident underscores the importance of robust IT resilience for maintaining continuous manufacturing and supply‑chain activities.